<?xml version="1.0"?>
<Articles JournalTitle="Frontiers in Biomedical Technologies">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Frontiers in Biomedical Technologies</JournalTitle>
      <Issn>2345-5837</Issn>
      <Volume>2</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>09</Month>
        <Day>30</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Radiosynthesis and Animal Studies of 111In-DTPA-bis-alendronate Complex</title>
    <FirstPage>163</FirstPage>
    <LastPage>171</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ashraf</FirstName>
        <LastName>Fakhari</LastName>
        <affiliation locale="en_US">Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>R. Jalilian</LastName>
        <affiliation locale="en_US">1- Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.&#xD;
2- Radiation Application Research School, Nuclear Science and Technology Research Institute, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Shafiee Ardestani</LastName>
        <affiliation locale="en_US">Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fariba</FirstName>
        <LastName>Johari Deha</LastName>
        <affiliation locale="en_US">Radiation Application Research School, Nuclear Science and Technology Research Institute, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Mirzaie</LastName>
        <affiliation locale="en_US">Radiation Application Research School, Nuclear Science and Technology Research Institute, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sedigheh</FirstName>
        <LastName>Moradkhan</LastName>
        <affiliation locale="en_US">Radiation Application Research School, Nuclear Science and Technology Research Institute, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Khalaj</LastName>
        <affiliation locale="en_US">Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>01</Month>
        <Day>01</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>01</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Purpose- In order to develop new bone imaging agent based on bisphosphonate
moiety, an alendronate based complex was designed and prepared in this study.
Methods- A DTPA-conjugated bis-alendronate analog (DTPA-bis-ALN) 3, was
prepared for possible bone imaging after radiolabeling with 111In. Radiolabeled
DTPA-bis-ALN complex was prepared starting radionuclide in chloride form and
DTPA-bis-ALN in 30-90 min at 50-60&#xB0;C in acetate buffer followed by solid phase
purification on C18 Sep-Pak cartridge. RTLC was used for radiochemical purity
determination followed by log P determination, stability studies, hydroxyl apatite&#xA0;tests and biodistribution studies in normal rats and imaging.
Results- Specific activity 1.1-1.3 TBq/mmmol was obtained for 111In-complex. The&#xA0;log Ps was calculated 0.48 for the complex consistent with water soluble complexes&#xA0;followed by stability test. The biodistribution of the labeled compound in normalrats demonstrated activity uptake in kidneys.
Conclusions- The anionic property of poly-dentate complex led to renal excretion&#xA0;instead of bone accumulation. These data showed that the developed complexes are&#xA0;not suitable agents for bone imaging as expected.</abstract>
    <web_url>https://fbt.tums.ac.ir/index.php/fbt/article/view/66</web_url>
    <pdf_url>https://fbt.tums.ac.ir/index.php/fbt/article/download/66/56</pdf_url>
  </Article>
</Articles>
